MOESM1 of Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction

  • Roseanne Raphael (Creator)
  • Diana Purushotham (Creator)
  • Courtney Gastonguay (Creator)
  • Marla A. Chesnik (Creator)
  • Wai Meng Kwok (Contributor)
  • Hsiang En Wu (Contributor)
  • Sanjiv J Shah (Creator)
  • Shama P. Mirza (Contributor)
  • Jennifer L. Strande (Creator)



Additional file 1: Figure S1. Â Flow cytometry to assess platelet activation. Purified platelet samples were incubated with fluorescently labeled antibodies against CD62P and CD41 and subject to flow cytometry. Platelets positive for CD41Â +Â but negative for CD62P are non-activated. CD62P positive platelets are activated.
Date made available2016

Cite this